Assignee
PHARMA MAR SA
ES·61 granted patents·51 pending applications·748 citations·filing 1994–2025
Top patents by PatentIndex Score
112 records- 0194US11339180B2Antitumoral compoundsPHARMA MAR SA·Filed 2021·Granted May 24, 2022·3 cites·22 claims
- 0294US7420051B2Synthetic process for the manufacture of an ecteinaschidin compoundPHARMA MAR SA·Filed 2005·Granted Sep 2, 2008·29 cites·16 claims
- 0393US7410969B2Antitumoral analogs of ET-743PHARMA MAR SA·Filed 2005·Granted Aug 12, 2008·32 cites·66 claims
- 0492US7524956B2Hemisynthetic method and new compoundsPHARMA MAR SA·Filed 2007·Granted Apr 28, 2009·32 cites·6 claims
- 0590US12324806B2Method of treating SCLC and managing hepatotoxicityPHARMA MAR SA·Filed 2023·Granted Jun 10, 2025·2 cites·30 claims
- 0690US7795260B2Synthesis of naturally occurring ecteinascidins and related compoundsPHARMA MAR SA·Filed 2008·Granted Sep 14, 2010·9 cites·22 claims
- 0789US7348311B2Derivatives of dehydrodidemnin BPHARMA MAR SA·Filed 2005·Granted Mar 25, 2008·11 cites·14 claims
- 0889USRE39887EDehydrodidemnin BPHARMA MAR SA·Filed 2005·Granted Oct 16, 2007·12 cites·5 claims
- 0989US7241892B1Hemisynthetic method and new compoundsPHARMA MAR SA·Filed 2000·Granted Jul 10, 2007·40 cites·99 claims
- 1089US6710029B1Dehydrodidemnin BPHARMA MAR SA·Filed 2000·Granted Mar 23, 2004·28 cites·9 claims
- 1188US6867334B2Metabolites of ecteinascidin 743 formed by human cytochrome CYP3A4PHARMA MAR SA·Filed 2001·Granted Mar 15, 2005·37 cites·2 claims
- 1287US10538535B2Antitumoral compoundsPHARMA MAR SA·Filed 2018·Granted Jan 21, 2020·7 cites·51 claims
- 1387US7919493B2Anititumoral ecteinascidin derivativesPHARMA MAR SA·Filed 2007·Granted Apr 5, 2011·9 cites·47 claims
- 1487US7678765B2Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using themPHARMA MAR SA·Filed 2007·Granted Mar 16, 2010·9 cites·14 claims
- 1587US7247629B2Antitumoral analogs of et-743PHARMA MAR SA·Filed 2001·Granted Jul 24, 2007·28 cites·92 claims
- 1686US2026014148A1Method of treating sclc and managing neutropeniaPHARMA MAR SA·Filed 2025·Application pending·0 cites
- 1785US11332480B2Antitumoral compoundsPHARMA MAR SA·Filed 2018·Granted May 17, 2022·2 cites·20 claims
- 1885US2026076964A1Method of treating sclc and managing hepatotoxicityPHARMA MAR SA·Filed 2025·Application pending·0 cites
- 1985US2026076965A1Method of treating sclc and managing thrombocytopeniaPHARMA MAR SA·Filed 2025·Application pending·0 cites
- 2084US8012975B2Antitumoral analogs of ET-743PHARMA MAR SA·Filed 2006·Granted Sep 6, 2011·7 cites·74 claims
- 2184US7772241B2Variolin derivatives and their use as antitumor agentsPHARMA MAR SA·Filed 2009·Granted Aug 10, 2010·5 cites·25 claims
- 2283US12384800B2Antitumoral compoundsPHARMA MAR SA·Filed 2023·Granted Aug 12, 2025·0 cites·23 claims
- 2383US7947671B2Synthesis of naturally occuring ecteinascidins and related compoundsPHARMA MAR SA·Filed 2010·Granted May 24, 2011·7 cites·23 claims
- 2483US2023399344A1A lyophilized pharmaceutical compositionPHARMA MAR SA·Filed 2023·Application pending·0 cites
- 2583US2023416276A1Lyophilized pharmaceutical composition and uses of a crystallized form of lurbinectedinPHARMA MAR SA·Filed 2023·Application pending·0 cites
- 2683US2023399345A1Crystallized form of lurbinectedin and method of making the samePHARMA MAR SA·Filed 2023·Application pending·0 cites
- 2782US12440490B2Method of treating SCLC and managing thrombocytopeniaPHARMA MAR SA·Filed 2023·Granted Oct 14, 2025·0 cites·30 claims
- 2882US12433890B2Method of treating SCLC and managing neutropeniaPHARMA MAR SA·Filed 2023·Granted Oct 7, 2025·0 cites·30 claims
- 2982US7482429B2Kahalalide F and related compoundsPHARMA MAR SA·Filed 2001·Granted Jan 27, 2009·33 cites·49 claims
- 3082US7348310B2Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using themPHARMA MAR SA·Filed 2001·Granted Mar 25, 2008·13 cites·41 claims
- 3182US7115743B2Metabolites of ecteinascidin 743PHARMA MAR SA·Filed 2004·Granted Oct 3, 2006·17 cites·2 claims
- 3281US7767659B2Synthesis of naturally occurring ecteinascidins and related compoundsPHARMA MAR SA·Filed 2003·Granted Aug 3, 2010·10 cites·16 claims
- 3381US6011010ACytotoxic and antiviral compoundPHARMA MAR SA·Filed 1997·Granted Jan 4, 2000·32 cites·4 claims
- 3480US7763615B2Ecteinascidin analogs for use as antitumour agentsPHARMA MAR SA·Filed 2002·Granted Jul 27, 2010·16 cites·32 claims
- 3579US11713325B2Antitumoral compoundsPHARMA MAR SA·Filed 2022·Granted Aug 1, 2023·0 cites·22 claims
- 3678US9827257B2Antitumoral compoundsPHARMA MAR SA·Filed 2015·Granted Nov 28, 2017·5 cites·14 claims
- 3778US5834586ADehydrodidemnin BPHARMA MAR SA·Filed 1994·Granted Nov 10, 1998·38 cites·5 claims
- 3877US7473681B2Kahalalide FPHARMA MAR SA·Filed 2001·Granted Jan 6, 2009·16 cites·7 claims
- 3975US7495000B2Variolin derivatives and their use as antitumor agentsPHARMA MAR SA·Filed 2002·Granted Feb 24, 2009·7 cites·36 claims
- 4075US5786492AHalichondrinsPHARMA MAR SA·Filed 1997·Granted Jul 28, 1998·25 cites·4 claims
- 4173US11224663B2Antibody drug conjugatesPHARMA MAR SA·Filed 2014·Granted Jan 18, 2022·2 cites·30 claims
- 4273US7759345B2Antitumoral derivatives of ET-743PHARMA MAR SA·Filed 2002·Granted Jul 20, 2010·6 cites·20 claims
- 4373US7138547B2Antitumoral compoundsPHARMA MAR SA·Filed 2001·Granted Nov 21, 2006·9 cites·13 claims
- 4472US7320981B2Variolin derivatives as anti-cancer agentsPHARMA MAR SA·Filed 2001·Granted Jan 22, 2008·8 cites·45 claims
- 4572US7135494B2Antitumoral carbazolesPHARMA MAR SA·Filed 2001·Granted Nov 14, 2006·11 cites·28 claims
- 4672US6864283B2Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activityPHARMA MAR SA·Filed 2001·Granted Mar 8, 2005·5 cites·10 claims
- 4772US6153731ADehydrodidemnin BPHARMA MAR SA·Filed 1998·Granted Nov 28, 2000·30 cites·2 claims
- 4871US2023014782A1New solid state form of lurbinectedinPHARMA MAR SA·Filed 2020·Application pending·0 cites
- 4970US7507766B2Treatment of cancersPHARMA MAR SA·Filed 2001·Granted Mar 24, 2009·12 cites·9 claims
- 5069US7329666B2Derivatives of variolin BPHARMA MAR SA·Filed 2001·Granted Feb 12, 2008·11 cites·23 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PHARMA MAR SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →